Teriflunomid (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Teriflunomid" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

2^nd place

2^nd place

4^th place

3^rd place

1sciencedirect.com

149^th place

32^nd place

low place

low place

1mcgraw-hill.com

low place

132^nd place

1clinicaltrials.gov

5,225^th place

3,406^th place

6^th place

5^th place

archive.org

Breedveld, FC; Dayer, J-M (2000). „Leflunomide: mode of action in the treatment of rheumatoid arthritis”. Ann Rheum Dis 59: 841–849. DOI:10.1136/ard.59.11.841. PMID 11053058.

clinicaltrials.gov

ClinicalTrials.gov

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Magne D, Mézin F, Palmer G, Guerne PA (2006). „The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1beta and TNF-alpha”. Inflamm. Res. 55 (11): 469–75. DOI:10.1007/s00011-006-5196-x. PMID 17122964.
Boyd, B, Castaner, J (2005). „Teriflunomide”. Drugs of the Future 30 (11): 1102. DOI:10.1358/dof.2005.030.11.948823.
Breedveld, FC; Dayer, J-M (2000). „Leflunomide: mode of action in the treatment of rheumatoid arthritis”. Ann Rheum Dis 59: 841–849. DOI:10.1136/ard.59.11.841. PMID 11053058.

mcgraw-hill.com

books.mcgraw-hill.com

Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). „Chapter 52. Immunosuppressants, tolerogens, and immunostimulants”. Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 izd.). New York: McGraw-Hill. ISBN 0-07-142280-3.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Magne D, Mézin F, Palmer G, Guerne PA (2006). „The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1beta and TNF-alpha”. Inflamm. Res. 55 (11): 469–75. DOI:10.1007/s00011-006-5196-x. PMID 17122964.
Breedveld, FC; Dayer, J-M (2000). „Leflunomide: mode of action in the treatment of rheumatoid arthritis”. Ann Rheum Dis 59: 841–849. DOI:10.1136/ard.59.11.841. PMID 11053058.

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit